Kästner, David https://orcid.org/0009-0003-6004-8639
Hartmann, Holger
Freudenberg, Robert
Pretze, Marc https://orcid.org/0000-0002-6432-5694
Brogsitter, Claudia
Schultz, Michael K.
Kotzerke, Jörg
Michler, Enrico
Funding for this research was provided by:
Technische Universität Dresden
Article History
Received: 29 August 2024
Accepted: 30 April 2025
First Online: 27 May 2025
Declarations
:
: Not applicable.
: Not applicable.
: The author Michael K. Schultz is CSO (Chief Science Officer) of Perspective Therapeutics, Inc. The other authors declare no other competing interests.